Chapter 42. Pharmacist Prescribing of a Nicotine Replacement Therapy Medication
Regulation .01 Scope.LinkCopy Citation
This chapter does not limit or otherwise affect the right of an individual to practice pharmacy or any other health occupation that the individual is authorized to practice.
Regulation .02 Definitions.LinkCopy Citation
A.
In this chapter, the following terms have the meanings indicated.
B.
Terms Defined.
(1)
“Board” means the Maryland Board of Pharmacy.
(2)
“Nicotine replacement therapy medication” means a nicotine-based treatment, including inhalers, gums, lozenges, nasal sprays, and patches, approved by the United States Food and Drug Administration that assists an individual to cease the use of products that contain nicotine.
(3)
“Primary care practitioner” means a licensed health care practitioner who:
(a)
Provides an individual’s primary care services; and
(b)
Is the primary coordinator of health care services for the individual.
(4)
“Visit summary” means:
(a)
A written record of the nicotine replacement therapy medication dispensed;
(b)
The name and contact information for the prescribing pharmacist; and
(c)
The information on the importance of regular appointments with the individual’s primary care practitioner.
Regulation .03 Requirements to Prescribe and Dispense a Nicotine Replacement Therapy Medication.LinkCopy Citation
A.
Training Requirements.
(1)
Prior to prescribing and dispensing a nicotine replacement therapy medication, a pharmacist shall complete a training program developed for the prescribing of a nicotine replacement therapy medication approved by the Board that is:
(a)
Offered by an accredited school of pharmacy;
(b)
Offered by an accredited school of medicine; or
(c)
Accredited by the Accreditation Council for Pharmacy Education.
(2)
A pharmacist who obtained training to prescribe a nicotine replacement therapy medication as part of their formal education is exempt from completing an additional training program.
B.
Standard Procedures. When an individual requests a nicotine replacement therapy medication, a pharmacist shall:
(1)
Provide the individual with appropriate counseling in the use of the prescribed nicotine replacement therapy medication;
(2)
Provide the individual with a visit summary;
(3)
Refer the patient to the individual’s primary care provider for additional care; and
(4)
Record the prescribing and dispensing of the nicotine replacement therapy medication in any health record maintained for the individual by the pharmacist.
Chapter annotations
Authority: Health Occupations Article, §§12-205 and 12-514, Annotated Code of Maryland
History: Effective date: October 14, 2024 (51:20 Md. R. 899)